Self-assembled nanoparticles of poly(lactide)-Vitamin E TPGS copolymers for oral chemotherapy

International Journal of Pharmaceutics

Volumn 324, Issue 2, 2006, Pages 191-198

  Zhang, Zhiping ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biodegradable polymers; Cancer; Cancer nanotechnology; GI barrier; Nanomedicine; Oral drug delivery; Taxol

Indexed keywords

ALPHA TOCOPHEROL; COPOLYMER; NANOPARTICLE; PACLITAXEL; POLYLACTIDE;

ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HT29; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DIALYSIS; DRUG FORMULATION; DRUG RELEASE; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; INTERNALIZATION; INTESTINE; PH; PRIORITY JOURNAL; SIMULATION; STATISTICAL SIGNIFICANCE; STOMACH;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CACO-2 CELLS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; SOLUBILITY; VITAMIN E;

EID: 33749663431     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.06.013     Document Type: Article

References (37)

1. Bittner B., Guenzi A., Fullhardt P., Zuercher G., Gonzalez R.C.B., and Mountfield R.J. Improvement of the bioavailability of colchicine in rats by co-administration of d-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid. Arzneimittelforschung 52 (2002) 684-688
2. Bogman K., Zysset Y., Degen L., Hopfgartner G., Gutmann H., Alsenz J., and Drewe J. P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin. Pharmacol. Ther. 77 (2005) 24-32
3. Bonduelle S., Carrier M., Pimienta C., Benoit J.P., and Lenaerts V. Tissue concentration of nanoencapsulated radiolabelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits. Eur. J. Pharm. Biopharm. 42 (1996) 313-319
4. Boudreaux J.P., Hayes D.H., Mizrahi S., Maggiore P., Blazek J., and Dick D. Use of water-soluble liquid Vitamin-E to enhance cyclosporine absorption in children after liver-transplant. Transplant. Proc. 25 (1993) 1875
5. Chang T., Benet L.Z., and Hebert M.F. The effect of water-soluble Vitamin-E (TPGS) on oral cyclosporine pharmacokinetics in healthy-volunteers. Clin. Pharmacol. Ther. 57 (1995) 163
6. Chang T., Benet L.Z., and Hebert M.F. The effect of water-soluble Vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 59 (1996) 297-303
7. Desai M.P., Labhasetwar V., Walter E., Levy R.J., and Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14 (1997) 1568-1573
8. Dintaman J.M., and Silverman J.A. Inhibition of P-glycoprotein by d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res. 16 (1999) 1550-1556
9. Donehower R.C., Rowinsky E.K., Grochow L.B., and Longnecker S.M. Phase I trial of Taxol in patients with advanced cancer. Cancer Treatment Rep. 71 (1987) 1171-1177
10. Eiseman J.L., Eddington N.D., Leslie J., Macauley C., Sentz D.L., Zuhowski M., Kujawa J.M., Young D., and Egorin M.J. Plasma pharmacokinetics and tissue distribution of paclitaxel in Cd2f1 mice. Cancer Chemother. Pharmacol. 34 (1994) 465-471
11. Feng S.S., and Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58 (2003) 4087-4114
12. Feng S.S., Mu L., Win K.Y., and Huang G.F. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr. Med. Chem. 11 (2004) 413-424
13. Goldberg H., Ling V., Wong P.Y., and Skorecki K. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem. Biophys. Res. Commun. 152 (1988) 552-558
14. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
15. Itoh K., Kubo W., Fujiwara M., Watanabe H., Miyazaki S., and Attwood D. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol. Pharma. Bull. 29 (2006) 343-347
16. Ke W.T., Lin S.Y., Ho H.O., and Sheu M.T. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. J. Control. Rel. 102 (2005) 489-507
17. Lin W.J., Juang L.W., and Lin C.C. Stability and release performance of a series of pegylated copolymeric micelles. Pharm. Res. 20 (2003) 668-673
18. Liu G., Franssen E., Fitch M.I., and Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J. Clin. Oncol. 15 (1997) 110-115
19. Lopes N.M., Adams E.G., Pitts T.W., and Bhuyan B.K. Cell kill kinetics and cell-cycle effects of taxol on human and hamster ovarian cell-lines. Cancer Chemother. Pharmacol. 32 (1993) 235-242
20. Luo L.B., Tam J., Maysinger D., and Eisenberg A. Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjugate Chem. 13 (2002) 1259-1265
21. Malingre M.M., Beijnen J.H., and Schellens J.H.M. Oral delivery of taxanes. Invest. New Drugs 19 (2001) 155-162
22. Mu L., and Feng S.S. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol (R)). J. Control. Rel. 80 (2002) 129-144
23. Mu L., and Feng S.S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R)): PLGA nanoparticles containing Vitamin E TPGS. J. Control. Rel. 86 (2003) 33-48
24. Mu L., and Feng S.S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm. Res. 20 (2003) 1864-1872
25. Panchagnula R. Pharmaceutical aspects of paclitaxel. Int. J. Pharm. 172 (1998) 1-15
26. Rege B.D., Kao J.P.Y., and Polli J.E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16 (2002) 237-246
27. Rowinsky E.K., Onetto N., Canetta R.M., and Arbuck S.G. Taxol-the 1st of the taxanes, an important new class of antitumor agents. Semin. Oncol. 19 (1992) 646-662
28. Ryu J.G., Jeong Y.I., Kim I.S., Lee J.H., Nah J.W., and Kim S.H. Clonazepam release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) triblock copolymers. Int. J. Pharm. 200 (2000) 231-242
29. Savic R., Luo L.B., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
30. Sokol R.J., Johnson K.E., Karrer F.M., Narkewicz M.R., Smith D., and Kam I. Improvement of cyclosporine absorption in children after liver-transplantation by means of water-soluble Vitamin-E. Lancet 338 (1991) 212-215
31. Sparreboom A., vanAsperen J., Mayer U., Schinkel A.H., Smit J.W., Meijer D.K.F., Borst P., Nooijen W.J., Beijnen J.H., and vanTellingen O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 94 (1997) 2031-2035
32. Varma M.V.S., and Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur. J. Pharm. Sci. 25 (2005) 445-453
33. Wani M.C., Taylor H.L., and Wall M.E. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia. J. Am. Chem. Soc. 93 (1971) 2325-2327
34. Win K.Y., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722
35. Win K.Y., and Feng S.S. In vitro and in vivo studies on vitamin E TPGS-emulsifed poly(d,l-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27 (2006) 2285-2291
36. Yoo H.S., and Park T.G. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J. Pharm. Sci. 93 (2004) 488-495
37. Zhang Z.P., and Feng S.S. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27 (2006) 262-270